Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts

BACKGROUND: Bone is one of the most frequent metastatic sites of advanced breast cancer. Current therapeutic agents aim to inhibit osteoclast-mediated bone resorption but only have palliative effects. During normal bone remodeling, the balance between bone resorption and osteoblast-mediated bone for...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuxiang, Cao, Minghui, Palomares, Melanie, Wu, Xiwei, Li, Arthur, Yan, Wei, Fong, Miranda Y., Chan, Wing-Chung, Wang, Shizhen Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198446/
https://www.ncbi.nlm.nih.gov/pubmed/30348200
http://dx.doi.org/10.1186/s13058-018-1059-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198446/
https://www.ncbi.nlm.nih.gov/pubmed/30348200
http://dx.doi.org/10.1186/s13058-018-1059-y

Ejemplares similares